results

Euro NCAP to Launch New 2025 Car Safety Results

WhatLatest Euro NCAP results published online and via social media.WhenWednesday 15 October - 11:00 a.m. CEST.WhereGo to Euro NCAP's Press Releases or…

3 months ago

EverQuote to Announce Third Quarter 2025 Financial Results on November 3, 2025

October 13, 2025 16:10 ET  | Source: EverQuote, Inc. CAMBRIDGE, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq:…

3 months ago

HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress

The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal cell carcinoma patients after progression on first-line therapies…

4 months ago

NTG Nordic Transport Group A/S – Q3 2025 Conference Call

October 10, 2025 04:00 ET  | Source: NTG Nordic Transport Group A/S NTG Nordic Transport Group A/S – Q3 2025…

4 months ago

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data 50 mg once-daily dose of obefazimod led…

4 months ago

Kia Announces September 2025 Global Sales Results

September 2025 global sales of 268,238 units, up 7.3% Y/ySales in Korea climbed to 49,001 units, up 28.5% Y/yOutside of…

4 months ago

Euro NCAP to Launch New SAFER TRUCKS Results

WhatLatest Euro NCAP truck safety results published online and via social media.WhenTuesday 30 September - 11:00 a.m. CEST.WhereGo to Euro NCAP's Press…

4 months ago

Silynxcom Announces First Half of 2025 Financial Results, Expands Client Diversity and Raised $2.9M to Support Growth

September 26, 2025 16:05 ET  | Source: Silynxcom Ltd. Netanya, Israel, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE…

4 months ago

Maris-Tech Announces Financial Results for the Six Months Ended June 30, 2025

September 26, 2025 16:04 ET  | Source: Maris-Tech Ltd. The company continues to advance AI-powered video streaming and edge computing…

4 months ago

Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer…

4 months ago